China could challenge the Pfizer deal

Pfizer employee in Cambridge At present Pfizer and AstraZeneca hold the number one and two spots in the Chinese drugs market, accounting for over 15% of the market.

Ian Read, the chief executive of Pfizer, carries a coin in his pocket. About the size and weight of a £2 piece, on one side it urges "straight talk" while on the other are embossed the words "own it". The coin is available to all Pfizer's staff and is part of the "culture" Mr Read, a Scot, wants to see in his business.

Whether he flashed the coin during his discussions with the UK government over the possibility of Pfizer buying AstraZeneca is unknown, at least to me. But what is certainly true is that he doesn't quite "own" the deal - ministers will make sure of that - and however much "straight talk" he engages in, many will think he is spinning a line.

Two elements have now come into sharp focus. One is the government's attitude to the deal, which according to two very senior figures in Whitehall is warming up rapidly.

The other is China - which will be keeping a watchful eye on events in the City involving two drugs companies that occupy positions one and two in the Chinese pharmaceuticals market.

First, the government. One senior figure I spoke to today made a passionate defence of Britain remaining an "open country" i.e open to foreign takeovers and, hopefully, foreign investment. Listing Cisco, GE Healthcare and IBM as large American corporates that have brought jobs to the UK, the person said that calls for greater powers for governments to intervene should be treated very warily unless there was a truly "asymmetric" relationship - for example a closed economy attempting to buy up UK intellectual property with no reciprocal arrangements. Russia and China are names that spring to mind.

"Would anyone seriously say now that the Indian takeover of Jaguar Land Rover has been bad for the British economy and British jobs?" the person, who is very close to the Prime Minister, said with a degree of incredulity.

Another person in government who is intimately involved has also been waxing lyrical about how the deal could actually be a shot in the arm for the UK's life sciences sector. With patent box incentives to be exploited (products invented here receive preferential tax treatment) and corporation tax levels lower than in the US, the person said that any deal would be trumpeted as a vindication of the government's policies.

Mr Read has clearly been telling ministers that Britain is an attractive place for Pfizer. I am sure he would consider a secondary listing in London if that eased political concerns. The business has already committed to domiciling in the UK.

Mr Read will give no guarantees, as until he has seen AstraZeneca's books Pfizer will not know precisely what they are taking over. Mr Read does not want to "do an Irene" - a reference to the chief executive of Kraft, Irene Rosenfeld, who made a promise on UK jobs during the takeover of Cadbury that she could not honour.

The maximum pledge Mr Read appears to feel comfortable with is that there will be no net loss of jobs and that Pfizer post-deal will employ the same number of people in the UK as Pfizer and AstraZeneca together employ at the moment - just over 10,000 people. I am sure he will leave a suggestion in the air that it could be far higher and that further investment will follow. Pfizer will also point out that AstraZeneca is already cutting jobs in the UK.

AstraZeneca will be robust in its defence - I am sure refusing to talk unless the offer ticks up towards £50 a share or more. I am told the board is resolute that they do not need rescuing by an American business, however deep its pockets. It has been suggested that in 18 months' time, AstraZeneca's share price could be above £50 in any case without the need for the disruption any takeover entails. Shareholders are not always convinced, of course, by the case for "jam tomorrow".

Then there is China. At present Pfizer and AstraZeneca hold the number one and two spots in the Chinese drugs market, accounting for over 15% of the market. If the two come together, China is certain to investigate, possibly putting up major hurdles to any deal. Don't forget, the Chinese regulators successfully blocked the merger of Glencore and Xstrata for 15 months. In the end its pound of flesh constituted Glencore's sale of a copper mine in Peru for £3.5bn.

Straight talk or not, Mr Read knows that there is still a long way to go to get this deal over the line.

More on This Story

More from Kamal

The BBC is not responsible for the content of external Internet sites

More Business stories


BBC Business Live

    08:24: TOTAL SHARES

    Shares in French oil firm Total are understandably lower this morning following the death overnight of the company's widely respected chief executive Christophe de Margerie in a plan crash in Moscow. Total has opened down nearly 3% to €42.94.

    08:12: WHITBREAD
    General view of cup from a Costa Coffee shop,

    Revenue for the owner of Costa Coffee and Premier Inn was up 13% to £1.29bn for the six months ended 28 August. Whitbread chief executive Andy Harrison said: "The trading momentum of our strong first half performance has continued into the first few weeks of the second half and positions Whitbread well to deliver full year results in line with expectations."

    08:00: GKN RESULTS

    GKN, which makes parts of planes and cars, said sales fell of the third quarter - that's July to September - but profit rose. A stronger pound than last year caused much of the lost revenue. For the rest of the year, the motor and aerospace market will grow, while agriculture "looks set to continue its recent decline," it says.

    07:50: ARM CHIPS BBC Radio 4

    Simon Segars the boss of chipmaker ARM is on the Today programme. He says lots of companies license his firm's tech so he's not worried about competition from the likes of Intel, which is now targeting ARM's market. "Competition is a good thing," he says. He adds: "History has shown the technology solution that we produce is the one that goes into most devices. Virtually every smartphone in the world uses an ARM processor". So, safe to say he's not worried in the slightest then.

    ASOS webpage screengrab

    Online retailer ASOS has reported as 14% slump in profits to £46.9m. Last year ASOS reported profits of £54.7m. There are no surprises here, though. The firm has previously warned "disruption" from investment in warehousing and the launch of its new business in China would hurt profits and that remains the case. Boss Nick Robertson says the firm is "in a period of major investment that comes at a short term cost, but the medium-term benefits will be significant."

    07:20: ARM CHIPS

    ARM, which could well make the chips in your mobile phone, says it made $320m (£195.5m) of sales in the third quarter, up 12% compared with last year. It will probably sell $350m in the final three months of the year, it said.

    Reckitt Benckiser products

    Reckitt Benckiser says it now expects full year revenue growth at the lower end of its total revenue growth target of 4-5%. The firm "delivered a robust performance in tougher markets in the third quarter" it said.

    07:00: CHINA GROWTH BBC Radio 4

    China's economy grew by 7.3% in the three months to September, compared with expectations of 7.2%. But it's still the lowest growth in six years. The BBC's Chief Business Correspondent Linda Yueh tells the Today programme Chinese monetary policymakers want to slow the Chinese economic growth gradually and allow the rest of the world to get used to it. China is becoming a "middle income economy" she says and will revert to a normal path for a developed economy over time of around 3% to 4%.

    Via Twitter Linda Yueh Chief business correspondent

    tweets: My interview with CEO of Oscar de la Renta fashion house, Alex Bolen, from Talking Business

    06:41: ENGINEERING SKILLS Radio 5 live

    We don't have enough engineers in the UK or scientists for that matter argues Ann Watson of Semta, an engineering skills charity, on 5 live. She says: "We need a million scientists, engineers and technicians by 2020, We are starting to see a shortage in education; people training those recruits." The perception of engineering as a "dirty, oily industry" doesn't help, she says.

    06:30: STOCK MARKET Radio 5 live

    Jane Foley, senior currency strategist at Rabobank is on 5 live talking about the falling stock market. "If we see stocks fall more we may see companies bargain hunting," she says. So more firms may start purchasing each other.

    06:21: HEATHROW TRAVEL Radio 5 live

    Travel writer Simon Calder is on 5 live talking about the weather. He says he sees about 50 weather-related cancellations at Heathrow, so perhaps about 5% of flights so far. Flights to Frankfurt look hard to come by, he says.


    Heathrow airport has said this morning that around 10% of flights will be cancelled today as the remnants of Hurricane Gonzalo hit the UK. Flights with the 20 biggest carriers would be affected, it says. British Airways has already cancelled some ahead of the expected severe weather. The remains of the hurricane are predicted to bring heavy rain and gusts of up to 75mph in some areas, causing disruption to rush-hour travel. If you're travelling today it's worth checking before you arrive at the airport.

    06:02: TOTAL CEO DEATH Radio 5 live

    Christophe de Margerie, the chief executive of French oil company Total, has died in an air crash in Moscow. Sarah Rainsford, the BBC's correspondent in Moscow says poor weather with low visibility is a possible cause of the crash. His plane crashed when it collided with a snow-clearing machine killing him and three crew, she tells 5 live.

    06:01: Howard Mustoe Business reporter

    Good morning! Get in touch via email or on twitter @BBCBusiness.

    06:00: Matthew West Business reporter

    Morning folks, we have the latest public borrowing figures out at 9:30 today. But before that we have full year results from online retailer ASOS, and interim figures from Whitbread, plus the weather is promising to play havoc with the transport network today with 10% of flights out of Heathrow already cancelled this morning. We'll bring you everything as it happens.



From BBC Capital


  • Ade Adepitan at the ColosseumThe Travel Show Watch

    The challenge of providing disabled access at Europe’s leading ancient monuments

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.